These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32599008)

  • 1. Cyclodextrins: Potential therapeutics against atherosclerosis.
    Mahjoubin-Tehran M; Kovanen PT; Xu S; Jamialahmadi T; Sahebkar A
    Pharmacol Ther; 2020 Oct; 214():107620. PubMed ID: 32599008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligosaccharides as Potential Therapeutics against Atherosclerosis.
    Dabravolski SA; Sukhorukov VN; Melnichenko AA; Khotina VA; Orekhov AN
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.
    Zimmer S; Grebe A; Bakke SS; Bode N; Halvorsen B; Ulas T; Skjelland M; De Nardo D; Labzin LI; Kerksiek A; Hempel C; Heneka MT; Hawxhurst V; Fitzgerald ML; Trebicka J; Björkhem I; Gustafsson JÅ; Westerterp M; Tall AR; Wright SD; Espevik T; Schultze JL; Nickenig G; Lütjohann D; Latz E
    Sci Transl Med; 2016 Apr; 8(333):333ra50. PubMed ID: 27053774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrin-mediated conjugation of macrophage and liposomes for treatment of atherosclerosis.
    Gao C; Liu C; Chen Q; Wang Y; Kwong CHT; Wang Q; Xie B; Lee SMY; Wang R
    J Control Release; 2022 Sep; 349():2-15. PubMed ID: 35779655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential benefits of eicosapentaenoic acid on atherosclerotic plaques.
    Nelson JR; Wani O; May HT; Budoff M
    Vascul Pharmacol; 2017 Apr; 91():1-9. PubMed ID: 28263852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans.
    Irie T; Fukunaga K; Garwood MK; Carpenter TO; Pitha J; Pitha J
    J Pharm Sci; 1992 Jun; 81(6):524-8. PubMed ID: 1522488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutraceutical therapies for atherosclerosis.
    Moss JW; Ramji DP
    Nat Rev Cardiol; 2016 Sep; 13(9):513-32. PubMed ID: 27383080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-cyclodextrin inhibits cholesterol crystal-induced complement-mediated inflammation: A potential new compound for treatment of atherosclerosis.
    Pilely K; Bakke SS; Palarasah Y; Skjoedt MO; Bartels ED; Espevik T; Garred P
    Atherosclerosis; 2019 Apr; 283():35-42. PubMed ID: 30772772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential applications of mushrooms against some facets of atherosclerosis: A review.
    Amirullah NA; Zainal Abidin N; Abdullah N
    Food Res Int; 2018 Mar; 105():517-536. PubMed ID: 29433243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxypropylcyclodextrins in parenteral use. I: Lipid dissolution and effects on lipid transfers in vitro.
    Irie T; Fukunaga K; Pitha J
    J Pharm Sci; 1992 Jun; 81(6):521-3. PubMed ID: 1522487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes.
    Ohtani Y; Irie T; Uekama K; Fukunaga K; Pitha J
    Eur J Biochem; 1989 Dec; 186(1-2):17-22. PubMed ID: 2598927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological strategies to inhibit intra-plaque angiogenesis in atherosclerosis.
    Perrotta P; Emini Veseli B; Van der Veken B; Roth L; Martinet W; De Meyer GRY
    Vascul Pharmacol; 2019 Jan; 112():72-78. PubMed ID: 29933080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Ultrasound-Responsive Theranostic Cyclodextrin-Loaded Nanoparticle for Multimodal Imaging and Therapy for Atherosclerosis.
    Mehta S; Bongcaron V; Nguyen TK; Jirwanka Y; Maluenda A; Walsh APG; Palasubramaniam J; Hulett MD; Srivastava R; Bobik A; Wang X; Peter K
    Small; 2022 Aug; 18(31):e2200967. PubMed ID: 35710979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage Membrane-Encapsulated Dopamine-Modified Poly Cyclodextrin Multifunctional Biomimetic Nanoparticles for Atherosclerosis Therapy.
    Zhu L; Zhong Y; Yan M; Ni S; Zhao X; Wu S; Wang G; Zhang K; Chi Q; Qin X; Li C; Huang X; Wu W
    ACS Appl Mater Interfaces; 2024 Jun; 16(25):32027-32044. PubMed ID: 38867426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis.
    Borow KM; Nelson JR; Mason RP
    Atherosclerosis; 2015 Sep; 242(1):357-66. PubMed ID: 26253795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Reversal of Atherosclerosis by FDA-Approved Compound that Transforms Cholesterol into an Anti-Inflammatory "Prodrug".
    Mendelsohn AR; Larrick JW
    Rejuvenation Res; 2016 Jun; 19(3):252-5. PubMed ID: 27241174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
    Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
    J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary α-cyclodextrin reduces atherosclerosis and modifies gut flora in apolipoprotein E-deficient mice.
    Sakurai T; Sakurai A; Chen Y; Vaisman BL; Amar MJ; Pryor M; Thacker SG; Zhang X; Wang X; Zhang Y; Zhu J; Yang ZH; Freeman LA; Remaley AT
    Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28102587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases.
    Coisne C; Tilloy S; Monflier E; Wils D; Fenart L; Gosselet F
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27999408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.